In honor of “Rare Disease Day” on February 29, this edition of the BioLines Weekender is dedicated to the innovation being conducted at New Jersey companies working to bring therapies and cures to so many Patients who are waging courageous battles against approximately 7,000 Rare Diseases. These companies and these Patients inspire and enable our work at BioNJ.
This week we saw the important appointment of Robert Califf, M.D., as FDA Commissioner, a recognized global leader in cardiology, clinical research and medical economics. We look forward to working with Dr. Califf to insure that the agency continues to streamline the path to approval — enabling drugs and therapies to market faster and more efficiently…for the Patients who need them.
We had to note the latest issue of NJBIZ which, if you missed it, gave its take on the strength of New Jersey’s industry in its Quick Hits column. Click here to view. We couldn’t agree more!
Enjoy this latest edition of the Weekender chock full of SO many great stories — from the advancement of numerous clinical trials and the launch of game-changing partnerships to the extraordinary research being done at our universities and the investment in new innovative start-up biotech companies.
Click here to read this week’s Weekender.